View Test

Laboratory:

Genomics

Test Name:

MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (MEN2A) - RET GENE - (B)

Test Code: MD

Clinical Information:

Testing done for confirmation of clinical diagnosis in patients with a diagnosis of medullar thyroid carcinoma (MTC), pheochromocytoma, parathyroid adenoma or hyperplasia and a positive family history of the MEN2A-related cancers. Testing available for simplex cases when onset of cancer is <35 years of age. Testing involves sequencing of exons 10, 11, 13-16 RET gene. These exons account for 98% of patients with a clinical diagnosis of MEN2.
Testing of asymptomatic relatives available for patients with documented positive family history. Prior consultation with the WRHA Genetics & Metabolism Program is strongly recommended. All out-of-province testing subjected to final laboratory approval. For more information, see:
http://www.ncbi.nlm.nih.gov/books/NBK1257/

Collection Devices:

Preferred Device:	2 - EDTA 4 mL NO GEL Tube(s) - Full Tube Collection EDTA 4 mL NO GEL Tube(s) - Full Tube Collection Manufacturer: Becton Dickinson & Company Catalogue #: 367861
Alternate Device:	6 - Microtainer(s) - EDTA, NO GEL (0.5 mL) to fill line Microtainer(s) - EDTA, NO GEL (0.5 mL) to fill line Manufacturer: Becton Dickinson & Company Catalogue #: 363706

Specimen Required:

Blood: 8.0 mL

Pediatric Blood: 3.0 mL

Specimen must be kept at room temperature.

Referral:

Requisition:

_SH Molecular Diagnostic Lab Test Requisition (R250-10-09)

Reference Values:

An interpretive report from the reference laboratory will be forwarded to the physician.

Availability:

Extracted DNA is forwarded to an out-of-province laboratory for testing, if approved. Turnaround time is estimated to be 12 to 14 weeks.